Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CryoLife's BioDisc

This article was originally published in The Gray Sheet

Executive Summary

Company plans to file an IDE application in the fourth quarter for Phase III studies of its protein hydrogel device for repair of denucleated intervertebral discs, Atlanta firm announces May 30. Device uses a delivery system with a dual chamber applicator, allowing the surgeon to inject the biomaterial in the void created by the removal of disc materials. Animal studies are currently underway and should be complete by the third quarter, according to the firm. Separately, Cryolife confirms May 29 that the Colorado State University Research Foundation has filed a suit which alleges patent and intellectual property claims related to firm's SynerGraft technology
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT014950

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel